An engineered SARS-CoV-2 receptor-binding domain produced in Pichia pastoris as a candidate vaccine antigenMiladys Limonta‐Fernández, Gerardo Guillén, Jorge Valdés-Hernández et al.|New Biotechnology|2022Cited by 58
Proteomic study via a non-gel based approach of meningococcal outer membrane vesicle vaccine obtained from strain CU385: A road map for discovering new antigensJeovanis Gil, Vladimir Besada, Lázaro Betancourt et al.|Human Vaccines|2009Cited by 26
The SARS-CoV-2 receptor-binding domain expressed in Pichia pastoris as a candidate vaccine antigenMiladys Limonta‐Fernández, Gerardo Guillén, Glay Chinea-Santiago et al.|medRxiv|2021Cited by 19
In-solution buffer-free digestion allows full-sequence coverage and complete characterization of post-translational modifications of the receptor-binding domain of SARS-CoV-2 in a single ESI–MS spectrumLuis Ariel Espinosa, Luis Javier González, Yassel Ramos et al.|Analytical and Bioanalytical Chemistry|2021Cited by 17
Pharmacokinetic study of Growth Hormone-Releasing Peptide 6 (GHRP-6) in nine male healthy volunteersAnia Cabrales, Luis Javier González, Jeovanis Gil et al.|European Journal of Pharmaceutical Sciences|2012Cited by 15